Omos Biosciences

Omos Biosciences is an early-stage biotechnology company developing approaches to cancer prevention through intervention at the pre-cancerous stage, rather than treatment of established disease.

The company's strategy builds on established precedents in early cancer prevention, such as polyp removal to prevent colorectal cancer and mole surveillance for skin cancer, with the aim of extending this preventive model more broadly.

Omos Biosciences is based at the BioEscalator, Oxford, and is backed by institutional and angel investors.